a randomized study in 20 patients with cancer was carried out to test the clinical efficacy of sodium-2-mercaptoethane sulfonate ( asta d-7093 ; mesnum ) as an agent to prevent urotoxic side effects ( in particular , hemorrhagic cystitis ) during cytostatic therapy with the oxazaphosphorines cyclophosphamide and ifosfamide .
C0010583
cyclophosphamide
C0020823
ifosfamide